Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
8
×
life sciences
national blog main
boston blog main
boston
boston top stories
fda
deals
investing
national top stories
new york blog main
san diego blog main
san francisco blog main
startups
atlas venture
cancer
decibel therapeutics
dyne therapeutics
gene therapy
hearing loss
myotonic dystrophy type 1
new enterprise associates
rare disease drugs
regenerative medicine
san diego top stories
achaogen
adams street partners
adeno-associated virus
akouos
allosteric
antibiotics
astellas pharma
astellas pharmaceuticals
atopic dermatitis
audentes therapeutics
autoimmune disorders
avidity biosciences
bempedoic acid
beta lactamase inhibitor
What
medicines
8
×
therapeutics
8
×
drug
ipo
ago
approved
clinic
company
developing
disease
dyne
fda
genetic
hearing
loss
muscle
new
rare
regenerative
targets
years
adding
address
adds
affects
aiming
allosteric
americans
bacteria
balance
biopharma
biotech
biotechs
black
brings
build
business
cancer
cholesterol
combo
Language
unset
Current search:
medicines
×
" clinical trials "
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections